- Report
- March 2024
- 198 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- July 2023
- 220 Pages
Global
From €1916EUR$1,990USD£1,648GBP
- Report
- May 2024
- 196 Pages
Global
From €4767EUR$4,950USD£4,100GBP
From €6260EUR$6,500USD£5,383GBP
- Report
- February 2024
- 150 Pages
Global
From €4093EUR$4,250USD£3,520GBP
- Report
- January 2024
- 200 Pages
Global
From €3996EUR$4,150USD£3,437GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4574EUR$4,750USD£3,934GBP
- Report
- August 2023
- 70 Pages
Middle East, Africa
From €4574EUR$4,750USD£3,934GBP
- Report
- August 2023
- 150 Pages
North America
From €4574EUR$4,750USD£3,934GBP
- Report
- August 2023
- 336 Pages
Global
From €5297EUR$5,500USD£4,555GBP
- Report
- February 2024
- 90 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 150 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- August 2023
- 145 Pages
Global
From €3033EUR$3,150USD£2,609GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 80 Pages
Europe
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
United States
From €4574EUR$4,750USD£3,934GBP
- Report
- November 2023
- 127 Pages
Global
From €4334EUR$4,500USD£3,727GBP
- Report
- March 2024
- 193 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- May 2024
- 192 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin.
Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more